
As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), the Mumbai-based company is recalling Cefdinir for oral suspension USP, 250 mg/5mL, packaged in 60 ml bottles.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3goZzLy
via
IFTTT
0 comments:
Post a Comment